Kiniksa Pharmaceuticals to Present at Jefferies London Healthcare Conference
Kiniksa Pharmaceuticals (Nasdaq: KNSA) has announced its upcoming participation in the 2024 Jefferies London Healthcare Conference. The company's management will engage in a fireside chat on Tuesday, November 19, 2024, at 12:00 p.m. GMT (7:00 a.m. ET).
Interested parties can access a live webcast of the presentation through the Investors section of Kiniksa's website at www.kiniksa.com. A replay will be made available on the company's website within 48 hours after the event.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha annunciato la sua prossima partecipazione alla 2024 Jefferies London Healthcare Conference. La direzione dell'azienda parteciperà a una conversazione informale martedì 19 novembre 2024, alle 12:00 GMT (7:00 ET).
Le parti interessate possono accedere a un webcast live della presentazione attraverso la sezione Investitori del sito web di Kiniksa su www.kiniksa.com. Una registrazione sarà disponibile sul sito dell'azienda entro 48 ore dopo l'evento.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) ha anunciado su próxima participación en la 2024 Jefferies London Healthcare Conference. La dirección de la empresa participará en una charla informal el martes 19 de noviembre de 2024, a las 12:00 p.m. GMT (7:00 a.m. ET).
Las partes interesadas pueden acceder a un webcast en vivo de la presentación a través de la sección de Inversores en el sitio web de Kiniksa en www.kiniksa.com. Una repetición estará disponible en el sitio de la empresa dentro de las 48 horas posteriores al evento.
키니크사 제약(Kiniksa Pharmaceuticals) (Nasdaq: KNSA)는 2024 제프리 런던 헬스케어 컨퍼런스에 참석할 예정이라고 발표했습니다. 회사 경영진은 2024년 11월 19일 화요일 GMT 기준 12:00 (ET 기준 7:00)에 편안한 대화 형식의 발표를 진행합니다.
관심 있는 분들은 키니크사의 웹사이트 www.kiniksa.com의 투자자 섹션을 통해 발표의 실시간 웹캐스트에 접속할 수 있습니다. 이벤트 후 48시간 이내에 회사 웹사이트에 다시 볼 수 있는 녹화본이 제공될 예정입니다.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) a annoncé sa prochaine participation à la 2024 Jefferies London Healthcare Conference. La direction de la société participera à une discussion informelle le mardi 19 novembre 2024, à 12h00 GMT (7h00 ET).
Les parties intéressées peuvent accéder à un webinaire en direct de la présentation via la section Investisseurs du site web de Kiniksa à www.kiniksa.com. Un enregistrement sera disponible sur le site de la société dans les 48 heures suivant l'événement.
Kiniksa Pharmaceuticals (Nasdaq: KNSA) hat seine bevorstehende Teilnahme an der 2024 Jefferies London Healthcare Conference bekannt gegeben. Die Geschäftsführung des Unternehmens wird am Dienstag, den 19. November 2024, um 12:00 Uhr GMT (7:00 Uhr ET) an einem lockeren Gespräch teilnehmen.
Interessierte Parteien können über den Investorenbereich der Website von Kiniksa unter www.kiniksa.com auf einen Live-Webcast der Präsentation zugreifen. Eine Wiederholung wird innerhalb von 48 Stunden nach der Veranstaltung auf der Website des Unternehmens verfügbar sein.
- None.
- None.
LONDON, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will participate in a fireside chat at the 2024 Jefferies London Healthcare Conference on Tuesday, November 19, 2024 at 12:00 p.m. Greenwich Mean Time (7:00 a.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website at www.kiniksa.com. A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About Kiniksa
Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor Contact
Jonathan Kirshenbaum
(781) 829-3949
jkirshenbaum@kiniksa.com
Kiniksa Media Contact
Tyler Gagnon
(781) 431-9100
tgagnon@kiniksa.com
FAQ
When is Kiniksa Pharmaceuticals (KNSA) presenting at the Jefferies London Healthcare Conference 2024?
How can I watch Kiniksa Pharmaceuticals' (KNSA) presentation at the Jefferies Conference?
Will there be a replay available of Kiniksa's (KNSA) Jefferies Conference presentation?
What type of presentation will Kiniksa Pharmaceuticals (KNSA) give at the Jefferies Conference?
